WRF
BIIB icon

Waddell & Reed Financial’s Biogen BIIB Stock Holding History

Waddell & Reed Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-93,232
Closed -$21.7M – 449
2019
Q3 		$21.7M Hold
93,232
– – 0.06% 320
2019
Q2 		$21.8M Hold
93,232
– – 0.05% 331
2019
Q1 		$22M Hold
93,232
– – 0.05% 331
2018
Q4 		$28.1M Hold
93,232
– – 0.08% 280
2018
Q3 		$32.9M Sell
93,232
-39,066
-30% -$13.5M 0.07% 278
2018
Q2 		$38.4M Sell
132,298
-30,824
-19% -$8.67M 0.09% 251
2018
Q1 		$44.7M Hold
163,122
– – 0.1% 230
2017
Q4 		$52M Buy
163,122
+4,544
+3% +$1.46M 0.12% 203
2017
Q3 		$49.7M Hold
158,578
– – 0.11% 215
2017
Q2 		$43M Sell
158,578
-193,633
-55% -$51.2M 0.09% 241
2017
Q1 		$96.3M Sell
352,211
-29,324
-8% -$8.29M 0.2% 131
2016
Q4 		$108M Sell
381,535
-167,617
-31% -$49.7M 0.24% 118
2016
Q3 		$172M Buy
549,152
+212,750
+63% +$63M 0.36% 75
2016
Q2 		$81.3M Sell
336,402
-933,080
-74% -$246M 0.17% 151
2016
Q1 		$330M Sell
1,269,482
-268,120
-17% -$70.8M 0.62% 48
2015
Q4 		$471M Sell
1,537,602
-616,567
-29% -$177M 0.76% 30
2015
Q3 		$629M Sell
2,154,169
-240,938
-10% -$79.6M 1.03% 20
2015
Q2 		$967M Sell
2,395,107
-273,300
-10% -$110M 1.38% 8
2015
Q1 		$1.13B Sell
2,668,407
-232,267
-8% -$91.5M 1.57% 9
2014
Q4 		$985M Buy
2,900,674
+75,693
+3% +$24.5M 1.37% 9
2014
Q3 		$935M Sell
2,824,981
-55,543
-2% -$18.3M 1.29% 14
2014
Q2 		$908M Buy
2,880,524
+312,390
+12% +$94M 1.33% 10
2014
Q1 		$786M Buy
2,568,134
+496,669
+24% +$158M 1.19% 12
2013
Q4 		$579M Buy
2,071,465
+616,724
+42% +$160M 0.93% 24
2013
Q3 		$350M Sell
1,454,741
-170,238
-10% -$38.1M 0.67% 46
2013
Q2 		$350M Buy
+1,624,979
New +$347M 0.73% 40

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Waddell & Reed Financial's BIIB Position: Q4 2019 in Review

Waddell & Reed Financial sold out of Biogen (BIIB) in Q4 2019, closing a stake of 93,232 shares — an estimated $21.7M sold.

Waddell & Reed Financial first reported a position in BIIB in Q2 2013 and held it in 26 quarters. The position peaked at $1.13B in Q1 2015. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Waddell & Reed Financial reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 93,232 Biogen shares in Q4 2019, an estimated $21.7M.
  • Waddell & Reed Financial first reported a position in Biogen in Q2 2013 and held it in 26 quarters.
  • Waddell & Reed Financial's Biogen position peaked at $1.13B in Q1 2015.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Waddell & Reed Financial's 13F filing for Q4 2019, filed 14 Feb 2020.